PMID- 17368527 OWN - NLM STAT- MEDLINE DCOM- 20070820 LR - 20181113 IS - 0091-3057 (Print) IS - 0091-3057 (Linking) VI - 86 IP - 4 DP - 2007 Apr TI - Serotonin receptor involvement in effects of restraint on female rat lordosis behavior. PG - 631-6 AB - Ovariectomized Fischer (CDF-344) rats, with bilateral cannulae in the mediobasal hypothalamus (MBH) near the ventromedial nucleus of the hypothalamus (VMN), were used to test the hypothesis that serotonin receptors in the VMN contribute to the lordosis-inhibiting effects of mild restraint. Rats were hormonally primed with 10 microg estradiol benzoate (EB) followed 48 h later with sesame seed oil. Four to six hours later (during the dark portion of the light-dark cycle), rats were pretested for sexual behavior. Thereafter, they were infused with saline, 2 microg of the serotonin (5-HT) 2 receptor agonist, (+/-)-2,5-dimethoxy-4-iodophenyl-2-aminopropane HCl (DOI), or 1 microg of the 5-HT(1A) receptor antagonist, N-2[4-(2-methoxyphenyl)-1-piperazinyl]ethyl-N-(2-pyridinyl) cyclohexanecarboxamide trihydrochloride (WAY100635). After a 5 min restraint, rats were tested for sexual receptivity. Rats infused with saline showed a significant decline in lordosis behavior after restraint. Infusion with either DOI or WAY100635 attenuated these effects of restraint. These findings extend earlier observations that the lordosis-disruptive effects of mild restraint include activation of 5-HT(1A) receptors in the VMN and are the first to implicate VMN 5-HT(2) receptors in protection against mild restraint. FAU - Uphouse, Lynda AU - Uphouse L AD - Department of Biology, Texas Woman's University, Denton, TX 76204, USA. Luphouse@mail.twu.edu FAU - Hiegel, Cindy AU - Hiegel C FAU - Perez, Erika AU - Perez E FAU - Guptarak, Jutatip AU - Guptarak J LA - eng GR - R25 GM055380/GM/NIGMS NIH HHS/United States GR - R01 HD028419/HD/NICHD NIH HHS/United States GR - R01 HD028419-12/HD/NICHD NIH HHS/United States GR - GM 55380/GM/NIGMS NIH HHS/United States GR - R01 HD28419/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20070216 PL - United States TA - Pharmacol Biochem Behav JT - Pharmacology, biochemistry, and behavior JID - 0367050 RN - 0 (Amphetamines) RN - 0 (Piperazines) RN - 0 (Pyridines) RN - 0 (Receptors, Serotonin) RN - 0 (Receptors, Serotonin, 5-HT2) RN - 0 (Serotonin Antagonists) RN - 0 (Serotonin Receptor Agonists) RN - 112692-38-3 (Receptor, Serotonin, 5-HT1A) RN - 1S4CJB5ZGN (estradiol 3-benzoate) RN - 4TI98Z838E (Estradiol) RN - 71IH826FEG (N-(2-(4-(2-methoxyphenyl)-1-piperazinyl)ethyl)-N-(2-pyridinyl)cyclohexanecarboxamide) RN - OOM10GW9UE (4-iodo-2,5-dimethoxyphenylisopropylamine) SB - IM MH - Amphetamines/administration & dosage MH - Animals MH - Estradiol/administration & dosage/analogs & derivatives MH - Female MH - Ovariectomy MH - Piperazines/administration & dosage MH - Posture MH - Pyridines/administration & dosage MH - Rats MH - Rats, Inbred F344 MH - Receptor, Serotonin, 5-HT1A/drug effects/physiology MH - Receptors, Serotonin/drug effects/*physiology MH - Receptors, Serotonin, 5-HT2/drug effects/physiology MH - Restraint, Physical/*physiology MH - Serotonin Antagonists/administration & dosage MH - Serotonin Receptor Agonists/administration & dosage MH - Sexual Behavior, Animal/drug effects/*physiology MH - Ventromedial Hypothalamic Nucleus/anatomy & histology/drug effects/physiology PMC - PMC2043475 MID - NIHMS25892 EDAT- 2007/03/21 09:00 MHDA- 2007/08/21 09:00 PMCR- 2008/04/01 CRDT- 2007/03/21 09:00 PHST- 2006/06/19 00:00 [received] PHST- 2007/01/22 00:00 [revised] PHST- 2007/02/07 00:00 [accepted] PHST- 2007/03/21 09:00 [pubmed] PHST- 2007/08/21 09:00 [medline] PHST- 2007/03/21 09:00 [entrez] PHST- 2008/04/01 00:00 [pmc-release] AID - S0091-3057(07)00078-0 [pii] AID - 10.1016/j.pbb.2007.02.007 [doi] PST - ppublish SO - Pharmacol Biochem Behav. 2007 Apr;86(4):631-6. doi: 10.1016/j.pbb.2007.02.007. Epub 2007 Feb 16.